Skip to main content

Sales & Marketing

  • Experts Debunk S&OP Myths

    Many early adopters of demand-driven strategies found that focusing on S&OP enabled substantial operational improvements. Yet, there are still many myths that prevent practitioners from incorporating data and technology. Let our experts help you wade through the falsehoods to adopt best-in-class practices.
  • The Perks of Integrated Business Planning

    Within the highly competitive branded coffee category, approximately 70 percent to 75 percent of volume is sold on promotion. Today, Massimo Zanetti Beverage USA is effectively using a unified system for trade promotion management and forecasting to capitalize on this huge opportunity.
  • Lindt & Sprungli Masters Personalized E-Commerce

    Lindt & Sprngli has hit its sweet spot not only in the manufacture and innovation of chocolate, but in e-commerce with the launch of a new cloud-based web store.
  • The Shoppers' Journey

    CGT interviews Kirk W. Wheeler, executive vice president, general manager, CPG Practice for Manthan Systems, about the prerequisites that consumer goods manufacturers must pass in order to understand and activate the new shopper's journey.
  • Mondelez, D.E Master Blenders to Join Forces

    The new company, to be called Jacobs Douwe Egberts (JDE), is expected to hold market positions in more than two dozen countries with a strong emerging market presence.
  • New Rules for Shopper Privacy

    IDC Retail Insights releases the results of its 2013 Annual Shopper survey, revealing that nearly two-thirds of consumers worry they don't have enough control over what retailers can know about them. Here are some more of the green lights and bright red lines retailers should abide when it comes to consumer dispositions on this topic of hot debate.
  • McCain Foods Appoints President, North America

    The new President takes over the role from Frank van Schaayk, who is retiring next October.
  • Merck Sells Consumer Care to Bayer for $14.2B

    Under the terms of the agreement, Bayer AG will acquire Mercks existing OTC business, including the global trademark and prescription rights for Claritin and Afrin.
X
This ad will auto-close in 10 seconds